Status:
COMPLETED
Utilization Patterns of Pulmicort in Real Life Practice
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
Brief Summary
The purpose of this study is to identify the potential issues during short and mid term utilization of Pulmicort hydro fluoroaklane (HFA) pressurized metered-dose inhaler (pMDI)and describe associated...
Eligibility Criteria
Inclusion
- Asthmatic patients with a diagnose of at least 12 months of duration before study inclusion
- Patients previously treated with Pulmicort CFC who have changed their treatment to Pulmicort HFA
Exclusion
- Disability that, from investigator point of view, prevent from complying the follow up schedule
- To have participated in any clinical study in the past 6 months
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT00660569
Start Date
January 1 2008
End Date
February 1 2009
Last Update
December 1 2010
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Barcelona, Barcelona, Spain
2
Research Site
Sabadell, Barcelona, Spain
3
Research Site
Alcorcón, Madrid, Spain
4
Research Site
Leganés, Madrid, Spain